Diebold Nixdorf Down 4%, Q3 Preview by Wedbush

Diebold Nixdorf (NYSE:DBD) shares were trading around 4% lower today. Analysts at Wedbush provided a company report on Diebold Nixdorf’s upcoming Q3 earnings results (ex. Oct 28), expecting good top-line growth to $1.0 billion weighted towards its Product segment as the company continues its roll-out of its DN Series and typical seasonality which tends to be weighted towards the back half of the year peaking in Q4. The analysts expect the gross margins to also increase to 28.3% as the more profitable DN Series increases as a percentage of total shipments.

The brokerage noted that it remains on the sidelines for now, but sees several metrics (backlog, order growth, and expected GM appreciation) that could lead to being more constructive, however, remains cautious due to the near-term impact of snarled logistics.

Symbol Price %chg
CRM.BA 16905 0.74
GOTO.JK 63 0
263750.KQ 32850 2.89
GOOGL.SW 1077.82 0
DBD Ratings Summary
DBD Quant Ranking
Related Analysis